Navigation Links
Amikacin, Peak Level

ProductsAmikacin, Peak Level
Company ARUP Laboratories
Item Amikacin, Peak Level
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Amikacin, Trough Level
2. Amikacin, Random Level
3. Leveling Pads (Feet, Set of 4), Spare part for ATA100
4. Level1® H-1200 Fast Flow Fluid Warmer
5. GoodKnight® 425 Bi-Level® Device
6. KnightStar® 330 Bi-Level® Ventilator
7. Lipoprotein (a) Control Level 3
8. Lipid Control Level 2
9. Lipid Control Level 1
10. Lipid Control Level 3
11. CRP Control Level 2 (Liquid)
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...y of Michigan says that it is possible to wish the...nking of a painkiller can trigger the brain to rel...// The study provides the first direct evidence t...icals, called endorphins, play a role in the pheno...
...c test to detect low grade gonadal mosaicism, whic...his test is particularly useful for couples with r...rent miscarriages, and couples over the age of 40 .... During, the process of Invitro fertilization, t...
...th a mutation in the gene BRCA1, which predisposes...y to develop the disease if they lose at least 10 ...archers studied more than 2000 women from five dif...he breast cancer susceptibility genes BRCA1 and BR...
...ng women these days to have their baby delivered a...n for religious regions. The trend may not be all ...// a link between c-section delivery and higher ri...ial attention regarding the newborns' oral health....
Other Medicine News:Health News:Wishing the pain away 2Health News:Watch out those of you planning for a predetermined Cesarean Section 2
(Date:9/3/2008)...se 3 Plans with FDA, PRINCETON, N.J., Sept. 3 /PR...oday that it successfully completed two key clinic... innovative low-dose, once-weekly,contraceptive p...product,code AG-200-15. The Phase 2b safety and ef... of ovulation suppression, cycle control and safet...
(Date:9/3/2008)... Evidence Pycnogenol(R) Lowers Joint, Pain, Sympto...g Cessation of the Ext...rding to the Center for,Disease Control (CDC), ost... on the rise. A new study published in the August ...ol(R), bark extract from the French maritime pine,...
(Date:9/3/2008)...e-FirstCall/ -- A sub-analysis of,the TRITON-TIMI ...grel,compared with clopidogrel significantly reduc... percent vs. 9.7 percent, p<0.0001), regardless,of... artery-opening,procedure known as percutaneous co...ntaneously during the longer-term maintenance phas...
(Date:9/2/2008)...tCall/ --, - This Analysis Showed That Multaq(R) ...in Patients With Atrial Fibrillation or Atrial Flu...Therapy, The results of a post-hoc analysis of th...at the clinical trial update session of the Europe... Germany. Previous results,from the landmark ATHEN...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease 28ESRD 29 Reform 24057 1Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease 28ESRD 29 Reform 24057 2SheKnows to Launch Bone Marrow Awareness Campaign and Add 50 000 New Donors 24055 1SheKnows to Launch Bone Marrow Awareness Campaign and Add 50 000 New Donors 24055 218 Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto 6567 118 Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto 6567 218 Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto 6567 3Vitamin A pushes breast cancer to form blood vessel cells 4062 1Vitamin A pushes breast cancer to form blood vessel cells 4062 2Vitamin A pushes breast cancer to form blood vessel cells 4062 3
...chnology has enabled more and more laboratory test...the central laboratory is hardly threatened with e...m and large labs are busier than ever before, and ...d reliability and ability to handle very large vol...position in the clinical landscape. , ,This is...
...D. ,Contributing Editor , ,Appendicitis ...ects 7% of individuals sometime in their lives. T...ch of intestine at the proximal colon, becomes obs...ection ensues, which can rapidly evolve to perfora... already elevated for children and those over 50, ...
Other Medicine Technology:Immunoassay Systems - Your Laboratory Workhorse 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3